Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail
?
-

Resources for You

-

Recall of Thymoglobulin [Anti-thymocyte Globulin (Rabbit)] 25mg/vial

 

 
DATE RECALL INITIATED: August 2, 2012
 
PRODUCT / LOT NUMBER / EXPIRATION DATE:
 
Thymoglobulin [Anti-thymocyte Globulin (Rabbit)] 25mg/vial
 

Lot Number
Expiration
Date          
C0062C01
Dec 2012  
C0072C01
Feb 2013
C0086C01
May 2013
C0094C01
July 2013
C0096C01
Aug 2013
C0098C01
Aug 2013
C0098C02
Aug 2013
C0098C03
Aug 2013
C0100C01
Aug 2013

 
 
MANUFACTURER:
 
Genzyme Corporation
A Sanofi Company
Framingham, MA
 
REASON:
 
Genzyme is initiating a voluntary recall of Thymoglobulin [Anti-thymocyte Globulin (Rabbit)] 25mg/vial. This recall was initiated when one Thymoglobulin lot (C0072) failed a periodic stability test for the molecular size distribution test. Additional lots, manufactured with comparable quality of the raw material considered to be the root cause of the atypical stability trend, are being recalled based on the potential risk for a stability failure prior to end of shelf life for aggregation. No other Thymoglobulin lots are involved in this recall. 
 
Genzyme has not identified any new safety risk to patients who have received Thymoglobulin from the implicated lot numbers, and there are no confirmed safety issues directly associated with the stability failure.
 
 
The information in this listing reflects CBER's best efforts to communicate information that has been reported to FDA. Its accuracy and comprehensiveness cannot be guaranteed.
 
 
-
-